Endogenous formation of N-nitrosamines from piperazine and their urinary excretion following antihelmintic treatment with piperazine citrate.
A R Tricker, R Kumar, M Siddiqi, M S Khuroo, R Preussmann
Index: Carcinogenesis 12(9) , 1595-9, (1991)
Full Text: HTML
Abstract
Antihelmintic treatment with piperazine (1,4-diazacyclohexane) for microfilarie parasitism results in the endogenous formation of piperazine-derived N-nitrosamines. The urinary excretion of these N-nitrosamines was determined by biochemical monitoring of 14 patients receiving 2 g piperazine citrate. The urinary excretion (mean +/- SD) of N-mononitrosopiperazine (MNPz) was 27.0 +/- 26.7 micrograms/day (range 0.6-96.0 micrograms/day). Trace levels of 0.73 +/- 0.92 micrograms/day N,N'-dinitrosopiperazine (DNPz) (range ND-2.8 micrograms/day) were also found in 7 of 14 urine samples. N-Nitroso-3-hydroxypyrrolidine (NHPYR), a metabolite of both MNPz and DNPz, was detected in 11 of 14 urine samples at a mean concentration of 1.74 +/- 1.72 micrograms/day (range ND-5.7 micrograms/day) and traces of N-nitrosodiethanolamine in two samples at levels of 0.3 and less than 0.1 micrograms/day. The results show that biochemical monitoring of urinary NHPYR may be a good indicator of endogenous MNPz formation. While DNPz was also detected in urine, conclusive validation for its endogenous formation could not be provided because no evidence was found for the presence of its major metabolite, N-nitroso-(2-hydroxyethyl)glycine in urine.
Related Compounds
Related Articles:
Some effects of piperazine citrate on skeletal muscle and central nervous system.
1987-11-01
[Arch. Int. Pharmacodyn. Ther. 290(1) , 104-16, (1987)]
Treatment of helminthic diseases.
1985-09-01
[Am. Fam. Physician 32(3) , 182-8, (1985)]
Synthesis and biological evaluation of novel benzothiazole clubbed fluoroquinolone derivatives.
2013-02-01
[J. Enzyme Inhib. Med. Chem. 28(1) , 1-10, (2013)]
Management of intestinal obstruction caused by ascariasis.
1997-04-01
[J. Pediatr. Surg. 32(4) , 585-7, (1997)]
Occupational asthma due to piperazine citrate.
2006-01-01
[J. Investig. Allergol. Clin. Immunol. 16(2) , 138-9, (2006)]